Nova Patents
AP2070A

Quinolinone derivatives

Abstract

Organic compounds having the formulas (I) and (II) are provided where the variables have the values described herein. Medicaments include an anti-cancer drug selected from 5-FU or CPT 11 and a compound of formula (I) or formula (II), a tautomer of the compound, a pharmaceutically acceptable salt of the compound, or a pharmaceutically acceptable salt of the tautomer in treatin along with an anti-cancer drug selected from 5-FU or CPT-11. The medicaments may be used in treating cancer. The use of a compound of formula (I) or formula (II), a tautomer of the compound, a pharmaceutically acceptable salt of the compound, or a pharmaceutically acceptable salt of the tautomer in treating cancer in conjunction with an anti-cancer drug selected from 5-FU or CPT-11 is also provided.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

Every citation, both ways

Citations
DocumentRelationOfficeCited during
WO0071129A1CitesWorld Intellectual Property Organization (WIPO)Search report
WO0128993A2CitesWorld Intellectual Property Organization (WIPO)Search report
WO0222598A1CitesWorld Intellectual Property Organization (WIPO)Search report